Viatris Inc. (LON:0A5V)

Market Cap	13.62B +26.7%
Revenue (ttm)	10.51B -6.1%
Net Income	-2.75B
EPS	-2.33
Shares Out	n/a
PE Ratio	n/a
Forward PE	6.52
Dividend	0.36 (2.26%)
Ex-Dividend Date	Nov 24, 2025

Volume	8,172
Average Volume	6,564
Open	15.78
Previous Close	15.88
Day's Range	15.66 - 16.10
52-Week Range	6.91 - 16.10
Beta	0.79
RSI	87.64
Earnings Date	Feb 26, 2026

About Viatris

Viatris Inc., together with its subsidiaries, operates as a healthcare company in North America, Europe, China, Taiwan, Hong Kong, Japan, Australia, New Zealand, rest of Asia, Africa, Latin America, and the Middle East. It operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. The company offers prescription brand drugs, generic drugs, complex generic drugs, and biosimilars. It also provides drugs in various therapeutic areas covering various noncommunicable and infectious diseases, including cardiovascular, CN...

• Industry: Pharmaceutical Preparations
• Founded: 1961
• Employees: 30,000
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0A5V

Financial Performance

Financial numbers in USD